Log in to search using one of your social media accounts:


What is heart failure? Three signs YOU could be suffering with deadly condition

HEART failure means the heart is not pumping blood around the body effectively - and can occur after a heart attack.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Authors: Reinsch M, Weinberger F Abstract Myocardial infarction leads to an irreversible loss of vital myocardial cells. The transplantation of new cardiomyocytes into the heart was first described over 20 years ago and represents a straightforward approach to remuscularize a damaged heart. Due to the lack of human cells a clinical application seemed ambitious; however, dramatic progress in stem cell biology over the last two decades has paved the way towards a clinical application. This is especially important as the prognosis for patients with terminal heart failure is still poor. The transpla...
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
Authors: Schlitt A, Guha M, Noutsias M, Klein HH, Klein HU Abstract Assessment of a permanent risk of life-threatening ventricular arrhythmia in patients with severely reduced left ventricular ejection fraction (LVEF
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
Conclusion Despite hemodynamic improvements with IABP support, patients with non-AMI cardiogenic shock still suffer poor outcomes. Patients with ischemic cardiomyopathy and low LVPCI fared significantly worse. These patients may warrant closer observation or earlier consideration of more advanced hemodynamic support.
Source: American Heart Journal - Category: Cardiology Source Type: research
AbstractLeft ventricular end-diastolic pressure (LVEDP) is an easily obtained, physiologically integrative measure of total LV function. LVEDP may be a useful prognostic measure in patients with acute myocardial infarction and utilised to guide medical therapy and assess risk for post myocardial infarction heart failure. To assess the utility of LVEDP as a prognostic measure in patients presenting with acute myocardial infarction. We performed an unrestricted search of electronic databases (1946 to March 2017) using a predefined search strategy. Publications were included if patients had an acute coronary syndrome and LVED...
Source: Journal of Cardiovascular Translational Research - Category: Cardiology Source Type: research
By DAVID SHAYWITZ, MD One word: implementation. Increasingly, I’m convinced that the underappreciated challenges of implementation describe the ever-expanding gap between the promise of emerging technologies (sensors, AI) and their comparatively limited use in clinical care and pharmaceutical research. (Updated disclosure: I am now a VC, associated with a pharma company; views expressed, as always, are my own.) Technology Promises Disruption Of Healthcare… Let’s start with some context. Healthcare, it is universally agreed, is “broken,” and in particular, many of the advances and conveniences...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Daimler Benz AG David Shaywitz Innovation Source Type: blogs
Publication date: Available online 11 December 2017 Source:Biocybernetics and Biomedical Engineering Author(s): Souhir Chabchoub, Sofienne Mansouri, Ridha Ben Salah Impedance cardiography (ICG) is a simple, non invasive and cost effective tool for estimating stroke volume, cardiac output and other hemodynamic parameters. It has been successfully used to diagnose several cardiovascular diseases, like the heart failure and myocardial infarction. In particular, valvular heart disease (VHD) is characterized by the affection of one or more heart valves: mitral, aortic, tricuspid or pulmonary valves and it is usually diagnosed ...
Source: Biocybernetics and Biomedical Engineering - Category: Biomedical Engineering Source Type: research
CONCLUSIONS: Because of the low positive predictive value of myocardial perfusion SPECT, utilization of the technique in the workup of cardiac patients undergoing noncardiac surgery has been inappropriate. Myocardial perfusion SPECT should be restricted to only clearly defined appropriate use criteria.  LIMITATIONS: Relatively small number of patients and retrospective design.   
Source: Annals of Saudi Medicine - Category: General Medicine Tags: ISSUE 6 Source Type: research
Key Points Ischemic post‐conditioning (IPoC) has been proposed as a strategy to mitigate the risk of ischemia‐reperfusion injury during primary percutaneous coronary intervention (PCI) for ST‐elevation myocardial infarction (STEMI). In this comprehensive and updated meta‐analysis of randomized controlled trials, IPoC during primary PCI for STEMI had no significant effect on all‐cause mortality, re‐infarction, or new‐onset heart failure compared with no post‐conditioning. Further strategies need to be prospectively evaluated to improve outcomes in patients with STEMI undergoing primary PCI.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Coronary Artery Disease Source Type: research
It remains unclear whether complete revascularization (CR) reduces the incidences of acute decompensated heart failure (ADHF) and adverse cardiac outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD). A total of 453 hemodynamically stable patients with STEMI and MVD were retrospectively evaluated; the patients were divided into two groups according to interventional strategy: CR (n = 240) and IR (n = 213). We analyzed the incidences of ADHF and major adverse cardiac events (MACE; a composite of all-cause mortality, myocardial infarction [MI] and any revas...
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
AbstractFollowing an ischemic event post systolic shortening (PSS) may occur. We investigated the association between PSS in patients with ST-segment elevation myocardial infarction (STEMI) following primary  percutaneous coronary intervention (pPCI) and occurrence of cardiovascular events at follow-up. A total of 373 patients admitted with STEMI and treated with pPCI were prospectively included in the study cohort. All patients were examined by echocardiography a median of 2 days after admission (int erquartile range, 1–3 days). PSS was measured by color tissue Doppler imaging (TDI) and speckle tracki...
Source: The International Journal of Cardiovascular Imaging - Category: Radiology Source Type: research
More News: Cardiology | Health | Heart | Heart Attack | Heart Failure